Top Regulatory News Stories – Week Ending November 3, 2017
This week saw the approval of two new molecular entities by the FDA along with a strong advisory panel recommendation. Here is my recap of the top regulatory news stories to follow: Valeant Pharmaceuticals has won U.S. FDA approval for its glaucoma drug Vyzulta ending a more than two-year effort to bring the drug to[…]